MYCN inhibits TrkC-mediated differentiation in neuroblastoma cells via disruption of the PKA signalling pathway

Ratner N, Brodeur GM, Dale RC, Schor NF. The “neuro” of neuroblastoma: neuroblastoma as a neurodevelopmental disorder. Ann Neurol. 2016;80:13–23.

Google Scholar 

Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackall CL, Diller L, et al. Neuroblastoma. Nat Rev Dis Primers. 2016;2:16078.

Google Scholar 

Irwin MS, Naranjo A, Zhang FF, Cohn SL, London WB, Gastier-Foster JM, et al. Revised neuroblastoma risk classification system: a report from the Children’s Oncology Group. J Clin Oncol. 2021;39:3229–41.

Google Scholar 

Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362:2202–11.

Google Scholar 

Park JR, Bagatell R, London WB, Maris JM, Cohn SL, Mattay KK, et al. Children’s Oncology Group’s 2013 blueprint for research: neuroblastoma. Pediatr Blood Cancer. 2013;60:985–93.

Google Scholar 

Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med. 1993;328:847–54.

Google Scholar 

Brodeur GM, Minturn JE, Ho R, Simpson AM, Iyer R, Varela CR, et al. Trk receptor expression and inhibition in neuroblastomas. Clin Cancer Res. 2009;15:3244–50.

Google Scholar 

Brodeur GM, Nakagawara A, Yamashiro DJ, Ikegaki N, Liu XG, Azar CG, et al. Expression of TrkA, TrkB and TrkC in human neuroblastomas. J Neurooncol. 1997;31:49–55.

Google Scholar 

Higashi M, Sakai K, Fumino S, Aoi S, Furukawa T, Tajiri T. The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and neural development. Surg Today. 2019;49:721–7.

Google Scholar 

Kogner P, Barbany G, Dominici C, Castello MA, Raschella G, Persson H. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res. 1993;53:2044–50.

Google Scholar 

Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst. 1993;85:377–84.

Google Scholar 

Ho R, Eggert A, Hishiki T, Minturn JE, Ikegaki N, Foster P, et al. Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res. 2002;62:6462–6.

Google Scholar 

Matsumoto K, Wada RK, Yamashiro JM, Kaplan DR, Thiele CJ. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res. 1995;55:1798–806.

Google Scholar 

Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol. 1994;14:759–67.

Google Scholar 

Nakamura K, Martin KC, Jackson JK, Beppu K, Woo CW, Thiele CJ. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Cancer Res. 2006;66:4249–55.

Google Scholar 

Ryden M, Sehgal R, Dominici C, Schilling FH, Ibanez CF, Kogner P. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis. Br J Cancer. 1996;74:773–9.

Google Scholar 

Yamashiro DJ, Liu XG, Lee CP, Nakagawara A, Ikegaki N, McGregor LM, et al. Expression and function of Trk-C in favourable human neuroblastomas. Eur J Cancer. 1997;33:2054–7.

Google Scholar 

Bouzas-Rodriguez J, Cabrera JR, Delloye-Bourgeois C, Ichim G, Delcros JG, Raquin MA, et al. Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis. J Clin Invest. 2010;120:850–8.

Google Scholar 

Seo E, Kim JS, Ma YE, Cho HW, Ju HY, Lee SH, et al. Differential clinical significance of neurotrophin-3 expression according to MYCN amplification and TrkC expression in neuroblastoma. J Korean Med Sci. 2019;34:e254.

Google Scholar 

Genevois AL, Ichim G, Coissieux MM, Lambert MP, Lavial F, Goldschneider D, et al. Dependence receptor TrkC is a putative colon cancer tumor suppressor. Proc Natl Acad Sci USA. 2013;110:3017–22.

Google Scholar 

Grotzer MA, Janss AJ, Fung K, Biegel JA, Sutton LN, Rorke LB, et al. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol. 2000;18:1027–35.

Google Scholar 

Grotzer MA, Janss AJ, Phillips PC, Trojanowski JQ. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors. Klin Padiatr. 2000;212:196–9.

Google Scholar 

Kim MS, Kim GM, Choi YJ, Kim HJ, Kim YJ, Jin W. TrkC promotes survival and growth of leukemia cells through Akt-mTOR-dependent up-regulation of PLK-1 and Twist-1. Mol Cells. 2013;36:177–84.

Google Scholar 

Jin W, Kim GM, Kim MS, Lim MH, Yun C, Jeong J, et al. TrkC plays an essential role in breast tumor growth and metastasis. Carcinogenesis. 2010;31:1939–47.

Google Scholar 

Schulte JH, Lindner S, Bohrer A, Maurer J, De Preter K, Lefever S, et al. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells. Oncogene. 2013;32:1059–65.

Google Scholar 

Huang M, Weiss WA. Neuroblastoma and MYCN. Cold Spring Harb Perspect Med. 2013;3:a014415.

Google Scholar 

Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984;224:1121–4.

Google Scholar 

Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985;313:1111–6.

Google Scholar 

Yue ZX, Huang C, Gao C, Xing TY, Liu SG, Li XJ, et al. MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastoma. Cancer Cell Int. 2017;17:43.

Google Scholar 

Campbell K, Gastier-Foster JM, Mann M, Naranjo AH, Van Ryn C, Bagatell R, et al. Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: a report from the Children’s Oncology Group. Cancer. 2017;123:4224–35.

Google Scholar 

Campbell K, Shyr D, Bagatell R, Fischer M, Nakagawara A, Nieto AC, et al. Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: a report from the International Neuroblastoma Risk Group (INRG) project. Pediatr Blood Cancer. 2019;66:e27819.

Google Scholar 

Chan HS, Gallie BL, DeBoer G, Haddad G, Ikegaki N, Dimitroulakos J, et al. MYCN protein expression as a predictor of neuroblastoma prognosis. Clin Cancer Res. 1997;3:1699–706.

Google Scholar 

Durbin AD, Zimmerman MW, Dharia NV, Abraham BJ, Iniguez AB, Weichert-Leahey N, et al. Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry. Nat Genet. 2018;50:1240–6.

Google Scholar 

Raieli S, Di Renzo D, Lampis S, Amadesi C, Montemurro L, Pession A, et al. MYCN drives a tumor immunosuppressive environment which impacts survival in neuroblastoma. Front Oncol. 2021;11:625207.

Google Scholar 

He S, Liu Z, Oh DY, Thiele CJ. MYCN and the epigenome. Front Oncol. 2013;3:1.

Google Scholar 

Tjaden B, Baum K, Marquardt V, Simon M, Trajkovic-Arsic M, Kouril T, et al. N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma. Sci Rep. 2020;10:7157.

Google Scholar 

Ng SWCY, Ng XY, Dua K, Chellappan DK Neuroblastoma: current advancements and future therapeutics. In: Advanced Drug Delivery Systems in the Management of Cancer. Elsevier; 2021.

Google Scholar 

Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol. 2000;10:381–91.

Google Scholar 

Emdal KB, Pedersen AK, Bekker-Jensen DB, Tsafou KP, Horn H, Lindner S, et al. Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation. Sci Signal. 2015;8:ra40.

Google Scholar 

Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci. 2006;361:1545–64.

Google Scholar 

Silvestri B, Mochi M, Garone MG, Rosa A. Emerging roles for the RNA-binding protein HuD (ELAVL4) in nervous system diseases. Int J Mol Sci. 2022;23:14606.

Google Scholar 

Duffy DJ, Krstic A, Halasz M, Schwarzl T, Fey D, Iljin K, et al. Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma. Oncotarget. 2015;6:43182–201.

Google Scholar 

Glebov-McCloud AGP, Saide WS, Gaine ME, Strack S. Protein Kinase A in neurological disorders. J Neurodev Disord. 2024;16:9.

Google Scholar 

Burvenich L, Rossler OG, Thiel G. Stimulus-induced activation of the glycoprotein hormone alpha-subunit promoter in human placental choriocarcinoma cells: major role of a tandem cAMP response element. Curr Issues Mol Biol. 2024;46:3218–35.

Google Scholar 

Thiel G, Al Sarraj J, Stefano L. cAMP response element binding protein (CREB) activates transcription via two distinct genetic elements of the human glucose-6-phosphatase gene. BMC Mol Biol. 2005;6:2.

Google Scholar 

Thiel G, Al Sarraj J, Vinson C, Stefano L, Bach K. Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription. J Neurochem. 2005;92:321–36.

Google Scholar 

Su Z, Fang H, Hong H, Shi L, Zhang W, Zhang W, et al. An investigation of biomarkers derived from legacy microarray data for their utility in the RNA-seq era. Genome Biol. 2014;15:523.

Google Scholar 

Diamant I, Clarke DJB, Evangelista JE, Lingam N, Ma’ayan A. Harmonizome 3.0: integrated knowledge about genes and proteins from diverse multi-omics resources. Nucleic Acids Res. 2025;53:D1016–D28.

Google Scholar 

Xu M, Sun M, Zhang X, Nguyen R, Lei H, Shern JF, et al. HAND2 assists MYCN enhancer invasion to regulate a noradrenergic neuroblastoma phenotype. Cancer Res. 2023;83:686–99.

Google Scholar 

Buechner J, Einvik C. N-myc and noncoding RNAs in neuroblastoma. Mol Cancer Res. 2012;10:1243–53.

Google Scholar 

Fuchs S, Danssmann C, Klironomos F, Winkler A, Fallmann J, Kruetzfeldt LM, et al. Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN. Nat Commun. 2023;14:3936.

Google Scholar 

Bray I, Bryan K, Prenter S, Buckley PG, Foley NH, Murphy DM, et al. Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival. PLoS One. 2009;4:e7850.

Google Scholar 

Misiak D, Hagemann S, Bell JL, Busch B, Lederer M, Bley N, et al. The MicroRNA landscape of MYCN-amplified neuroblastoma. Front Oncol. 2021;11:647737.

Google Scholar 

Schulte JH, Horn S, Otto T, Samans B, Heukamp LC, Eilers UC, et al. MYCN regulates oncogenic MicroRNAs in neuroblastoma. Int J Cancer. 2008;122:699–704.

Google Scholar 

He XY, Tan ZL, Mou Q, Liu FJ, Liu S, Yu CW, et al. microRNA-221 enhances MYCN via targeting nemo-like kinase and functions as an oncogene related to poor prognosis in neuroblastoma. Clin Cancer Res. 2017;23:2905–18.

Google Scholar 

Liu Q, Tian R, Yu P, Shu M. miR-221/222 suppression induced by activation of the cAMP/PKA/CREB1 pathway is required for cAMP-induced bidirectional differentiation of glioma cells. FEBS Lett. 2021;595:2829–43.

Google Scholar 

Harenza JL, Diamond MA, Adams RN, Song MM, Davidson HL, Hart LS, et al. Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines. Sci Data. 2017;4:170033.

Google Scholar 

Shea TB, Beermann ML, Leli U, Nixon RA. Opposing influences of protein kinase activities on neurite outgrowth in human neuroblastoma cells: initiation by kinase A and restriction by kinase C. J Neurosci Res. 1992;33:398–407.

Google Scholar 

Minakawa T, Kanki Y, Nakamura K, Yamashita JK. Protein kinase A accelerates the rate of early stage differentiation of pluripotent stem cells. Biochem Biophys Res Commun. 2020;524:57–63.

Google Scholar 

Kim G, Choe Y, Park J, Cho S, Kim K. Activation of protein kinase A induces neuronal differentiation of HiB5 hippocampal progenitor cells. Brain Res Mol Brain Res. 2002;109:134–45.

Google Scholar 

Wang S, Li Z, Shen H, Zhang Z, Yin Y, Wang Q, et al. Quantitative phosphoproteomic study reveals that protein kinase A regulates neural stem cell differentiation through phosphorylation of catenin beta-1 and glycogen synthase kinase 3β. Stem Cells. 2016;34:2090–101.

Google Scholar 

Sanchez S, Jimenez C, Carrera AC, Diaz-Nido J, Avila J, Wandosell F. A cAMP-activated pathway, including PKA and PI3K, regulates neuronal differentiation. Neurochem Int. 2004;44:231–42.

Google Scholar 

Chen L, Mu B, Li Y, Lu F, Mu P. DRR1 promotes neuroblastoma cell differentiation by regulating CREB expression. Pediatr Res. 2023;93:852–61.

Google Scholar 

Nahreini P, Andreatta CP, Prasad KN, Toribara NW. VP16CREB-induced differentiation of neuroblastoma. Indian J Pediatr. 2008;75:1009–13.

Google Scholar 

McGeary SE, Lin KS, Shi CY, Pham TM, Bisaria N, Kelley GM, et al. The biochemical basis of microRNA targeting efficacy. Science. 2019;366:eaav1741.

Google Scholar 

Qasim H, McConnell BK. AKAP12 signaling complex: impacts of compartmentalizing cAMP-dependent signaling pathways in the heart and various signaling systems. J Am Heart Assoc. 2020;9:e016615.

Google Scholar 

Kimura S, Lok J, Gelman IH, Lo EH, Arai K. Role of A-Kinase anchoring protein 12 in the central nervous system. J Clin Neurol. 2023;19:329–37.

Google Scholar 

Casala C, Gil-Guinon E, Ordonez JL, Miguel-Queralt S, Rodriguez E, Galvan P, et al. The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis. Carcinogenesis. 2013;34:268–76.

Google Scholar 

Lange I, Koster J, Koomoa DT. Calcium signaling regulates fundamental processes involved in Neuroblastoma progression. Cell Calcium. 2019;82:102052.

Google Scholar 

Lee AC, Shih YY, Zhou F, Chao TC, Lee H, Liao YF, et al. Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma. J Mol Med. 2019;97:325–39.

Google Scholar 

Brodeur GM. Spontaneous regression of neuroblastoma. Cell Tissue Res. 2018;372:277–86.

Google Scholar 

Reynolds CP, Matthay KK, Villablanca JG, Maurer BJ. Retinoid therapy of high-risk neuroblastoma. Cancer Lett. 2003;197:185–92.

Google Scholar 

Peinemann F, van Dalen EC, Enk H, Berthold F. Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation. Cochrane Database Syst Rev. 2017;8:CD010685.

Google Scholar 

Maher S, Wynne K, Zhernovkov V, Halasz M. A temporal (phospho-)proteomic dataset of neurotrophic receptor tyrosine kinase signalling in neuroblastoma. Sci Data. 2024;11:1111.

Google Scholar 

Yu F, Haynes SE, Teo GC, Avtonomov DM, Polasky DA, Nesvizhskii AI. Fast quantitative analysis of timsTOF PASEF data with MSFragger and IonQuant. Mol Cell Proteomics. 2020;19:1575–85.

Google Scholar 

Perez-Riverol Y, Bai J, Bandla C, Garcia-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50:D543–D52.

Google Scholar 

Maher S, Wynne, K., Zhernovkov, V. & Halasz, M. Temporal (phospho-)proteomic profiling of neurotrophic receptor tyrosine kinase signalling in neuroblastoma cells. PRIDE 2024. Accession number: PXD054441.

Maher S, Wynne, K., Zhernovkov, V. & Halasz, M. Temporal (phospho-)proteomic profiling of neurotrophic receptor tyrosine kinase signalling in neuroblastoma. figshare. 2024. Software. ID: 26863267.

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.

Google Scholar 

Wiredja DD, Koyuturk M, Chance MR. The KSEA App: a web-based tool for kinase activity inference from quantitative phosphoproteomics. Bioinformatics. 2017;33:3489–91.

Google Scholar 

Casado P, Rodriguez-Prados JC, Cosulich SC, Guichard S, Vanhaesebroeck B, Joel S, et al. Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal. 2013;6:rs6.

Google Scholar 

Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.

Google Scholar